Nutraceuticals sector executives raise concern over Biodiversity Act
The nutraceutical industry, which is at its nascent stage, offers significant socio-economic benefits with promising double-digit growth opportunities. At the end of 2019, the global nutraceutical industry was valued at $382 billion, and India at $5 billion. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 20, 2021 Category: Pharmaceuticals Source Type: news

India to start coronavirus vaccine exports as soon as Wednesday, starting with Bhutan
Two million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India (SII), will also be despatched to Bangladesh on Thursday, said officials briefed on the plans. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

Once COVID-19 vaccine vial opened, it needs to be used fully within four hours: Senior doctors
The first batch of Oxford COVID-19 Covishield vaccine had reached Delhi's central storage facility at Rajiv Gandhi Super Specialty Hospital (RGSSH) on January 12. The lot of Bharat Biotech-made Covaxin had reached there the next day, which is being used at six sites, including AIIMS and RML Hospital. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine
"Based on the safety and immunogenicity data of the phase 1 clinical trial, the company would be given permission for conducting phase 2 clinical trial," an official said on the condition of anonymity. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

People with fever, pregnant and breastfeeding women avoid Covaxin, says Bharat Biotech
The vaccine maker in the fact sheet on Covaxin, posted in its website, said the clinical efficacy of the vaccine is yet to be established and is being studied in Phase 3 clinical trial and hence it is important to appreciate that receiving the vaccine does not mean other precautions related to COVID- 19 need not be followed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

Immunocompromised people advised not to take Covaxin: Bharat Biotech releases detailed factsheet
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

Covishield not to be taken by people severely allergic to any of its ingredients: Serum Institute
According to the fact sheet for the vaccine recipient by the Serum Institute of India, one should not get the Covishield vaccine if the person had a severe allergic reaction after a previous dose of this vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of its COVID-19 vaccine
The company was given a fresh letter of comfort recently for supplying another 45 lakh doses of Covaxin. The doses will be dispatched as when the Ministry places orders with the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

NGT directs Telangana PCB to recover Rs 1.55 cr from pharma firms for causing pollution
The NGT passed the order after a committee recommended to impose environmental compensation for one year for all pharma formulation industries and six months to Shri Kartikeya Pharma which is engaged in Ayurvedic Ashwagandha extraction, as the pollution load is less. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 19, 2021 Category: Pharmaceuticals Source Type: news

Caplin Point arm inks strategic partnership with Canada's JAMP Pharma Group
C C Paarthipan, Chairman of Caplin Point Laboratories said: "We have targeted Canada as one of our key expansion areas in regulated markets and we are excited to work with JAMP, one of the fastest growing companies in Canada" (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2021 Category: Pharmaceuticals Source Type: news

India to ship vaccines to neighbours in few weeks
The first destinations would be in India ’s immediate neighbourhood, like Nepal, Bhutan, Bangladesh, Myanmar, Sri Lanka, Afghanistan, Maldives and Mauritius to help them kickstart their own vaccination processes against the coronavirus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2021 Category: Pharmaceuticals Source Type: news

COVID-19: India records lowest fatalities in eight months
The daily coronavirus infections fell below 14,000 for the second time this month taking India's COVID-19 caseload to 1,05,71,773, while 145 new fatalities were recorded, the lowest in around eight months, according to the Union Health Ministry data updated on Monday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2021 Category: Pharmaceuticals Source Type: news

Ascend Laboratories recalls over 20,000 bottles of antibacterial drug in US
The US-based Ascend Laboratories LLC is recalling 20,232 bottles of Cephalexin for oral suspension, USP, 125 mg per 5 mL, manufactured by Alkem Laboratories, according to the latest Enforcement Report by the US Food and Drug Administration. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2021 Category: Pharmaceuticals Source Type: news

Metropolis Healthcare to acquire Hitech Diagnostic Centre in a cash, stock deal
S P Ganesan, its promoter and founder, will be part of the leadership team for the next few years to enable a smooth transition and integration with Metropolis, the filing said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2021 Category: Pharmaceuticals Source Type: news

Seropositivity for COVID-19 found to be lesser in smokers, vegetarians: CSIR survey
The study which was piloted by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said of the 10,427 individuals, 1,058 (10.14 per cent) had antibodies against SARS-CoV-2. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 17, 2021 Category: Pharmaceuticals Source Type: news

India begins world's largest immunisation exercise today
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 16, 2021 Category: Pharmaceuticals Source Type: news

From Polio to Tetanus, five vaccines that saved the world before COVID-19 came along
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 16, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech to pay compensation if Covaxin causes side effects
"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 16, 2021 Category: Pharmaceuticals Source Type: news

Covid vaccination drive: Bharat Biotech to pay compensation if Covaxin causes side effects
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 16, 2021 Category: Pharmaceuticals Source Type: news

Indian pharma industry has risen to occasion during the pandemic: Satish Reddy
Currently, the Indian pharma industry is about $40 billion, with potential in the next 10 years to go to $120 billion to 130 billion. This can be done by building on the existing strengths, and by building on the newer strengths, which can take us there, Reddy said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2021 Category: Pharmaceuticals Source Type: news

Strides Pharma Science arm gets USFDA nod for HIV treatment drug
Drug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has received approval from the US health regulator for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, used to treat HIV. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2021 Category: Pharmaceuticals Source Type: news

Experts question govt vaccine purchase price, say it's higher
The government procurement price of Rs 200 per dose for Covishield, manufactured by Serum Institute, is higher than what the EU is said to be paying. The EU is paying euro 1.78 per dose (nearly Rs 159) for the Oxford/AstraZeneca vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 14, 2021 Category: Pharmaceuticals Source Type: news

India's Serum Institute to stockpile Novavax vaccine candidate from around April
"Upwards of 40-50 million doses per month is what we are trying to stockpile starting from April," he said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 14, 2021 Category: Pharmaceuticals Source Type: news

India's Serum Institute expects WHO emergency approval for AstraZeneca shot soon
"The emergency use licensure from the WHO (World Health Organization) should be available and coming through in the next week or two, hopefully, because we have submitted everything," Adar Poonawalla told. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 14, 2021 Category: Pharmaceuticals Source Type: news

India to treat homegrown COVID-19 vaccine same as AstraZeneca's
Administering Bharat Biotech's COVAXIN, a move cheered by nationalist politicians, has worried some health experts who consider it rushed, as the vaccine has only limited, "clinical-trial mode" approval. In addition to efficacy concerns, the close monitoring required for its use will be a massive challenge in a country of 1.35 billion people. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 14, 2021 Category: Pharmaceuticals Source Type: news

German vaccine institute praises efficacy of Oxford-AstraZeneca vaccine
Speaking during an online press briefing, the president of Germany's Paul Ehrlich Institute (PEI), Klaus Cichutek, said there had been some debate over the best usage pattern for the vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 14, 2021 Category: Pharmaceuticals Source Type: news

India wants Pfizer to do local study for approval: Official
Serum Institute of India, the local manufacturer of the vaccine developed by AstraZeneca and Oxford University, has done a similar study on more than 1,500 people over months before seeking and receiving emergency approval in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news

WHO asks Serum Institute of India for Covishield trial data to begin global supply
Serum Institute of India is one of the manufacturers that has signed up to supply up to 400 million doses of vaccines to the Covax Facility. In the first quarter, the company is expected to supply 200 million doses of the AstraZeneca/Oxford vaccine which it has developed in India and branded as Covishield. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news

Covid-19: An FAQ factsheet for Covishield vaccine by Serum Institute
The factsheet details information that would enable recipients to understand the benefits and common side-effects of the Covishield vaccine, to prevent Coronavirus Disease 2019 (COVID-19) caused by the coronavirus called SARS-CoV-2. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news

Granules gets American drug regulator's nod for diabetes management drug Metformin
The US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg, Granules said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news

Unichem Labs gets American drug regulator's nod to market generic Celecoxib capsules
The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA), Unichem said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech air-ships Covaxin coronavirus vaccine to 11 cities as of Tuesday
"After having received the government purchase order for 55 lakh doses, the company shipped the first batch of vaccines (each vial containing 20 doses)," Bharat Biotech said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 13, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech set to dispatch first consignment of Covaxin
"Today in the evening the first consignment is going out of Hyderabad.... (it is from ) Bharat Biotech. It is going to 11 destinations," an official told reporters after receiving the first consignment of Covishield vaccines. Covishield is developed by Oxford University and British-Swedish company AstraZeneca and manufactured by the Serum Institute of India (SII). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech inks pact with Precisa Medicamentos for Covaxin supplies to Brazil
The Brazilian Ambassador to India Andr Aranha Corra do Lago expressed keen interest on behalf of his government towards procuring the vaccine and in principle, it was understood between both parties that supplies of Covaxin to be prioritized for the public market through a direct procurement by the Brazilian government, it said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Four more COVID-19 vaccines are in pipeline: Health Ministry
Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccines also in the pipeline which are in advanced clinical trials in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

First Covishield vaccines consignment leaves Serum Institute's facility
Three temperature-controlled trucks rolled out of the Serum Institute gates shortly before 5 am and left for Pune airport, from where the vaccines will be flown across India. The trucks carried 478 boxes of the vaccines, each box weighing 32 kg, a source involved in the vaccine transport arrangements told PTI. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

First lot of COVID-19 vaccine vials to arrive in Kolkata on Tuesday
The first consignment of over 10.5 lakh vials of COVID-19 vaccines will be reaching Kolkata from Pune on Tuesday, a senior official of the state health department said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Vax populi: ‘Z+ security’ for pandemic era’s vials of gold
Companies, logistics firms, governments and hospitals are already ramping up infrastructure to safeguard vials of Covid vaccine against the looming risk of theft, burglary and pilferage. That ’s not all — both vaccine makers and governments need to be alert to the possibility of counterfeiting and a potential grey market. They admit to being wary of lax security at hospitals etc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Govt committed to buying another 4.5 crore doses of Covishield vaccine
Flights have started ferrying the vaccines to different cities from Pune from Tuesday morning. According to the purchase order placed on Monday, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Fight against COVID begins as first consignment of Covishield vaccines leave facility
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

View: India will play central role in equitable Covid-19 vaccine distribution across the world
The recent approval of COVID-19 vaccines for emergency use by India ’s regulator paves the way for actual vaccination to begin. In fact, preparations have been underway for quite some time. Vaccine production lines have been running to produce millions of doses even before clinical trials were concluded – a testament to the ability to innovate, even at significa nt financial risk. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Health secretary briefs par panel on COVID vaccine's development and distribution
The meeting of the panel is being held days before the start of the countrywide COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world's largest inoculation programme. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

Andhra Pradesh gets 4.96 lakh doses of Covaxin
State Health Commissioner Katamaneni Bhaskar said the first consignment of vaccine doses would be sufficient to vaccinate about 3.7 lakh health care workers in the first round beginning January 16. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2021 Category: Pharmaceuticals Source Type: news

India wants Serum Institute to lower price of AstraZeneca's Covid-19 vaccine
Senior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot, one of the sources said. Serum chief executive Adar Poonawalla had said in November the vaccine would be priced at about Rs 1,000 per dose for the private market in India and would cost the government about Rs 250 per dose. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2021 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic drug in the US market
The company has launched the product, which is a generic version of Teijin Ltd's Uloric tablets, after getting approval from the US Food and Drug Administration (USFDA), the company said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2021 Category: Pharmaceuticals Source Type: news

Government plans unique health IDs linked to Aadhaar info
Authorities plan to use the Covid inoculation programme to generate unique digital health IDs for citizens. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2021 Category: Pharmaceuticals Source Type: news

Covid-19 vaccine: Each vaccine vial, with 10 doses, must be used within 4 hours of opening
For instance, some vaccines under the Universal Immunisation Programme (UIP) can be used for about four weeks after the vial is opened (for the first time). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2021 Category: Pharmaceuticals Source Type: news

Covishield vaccine transport to start in less than 24 hours
Kool-Ex, a Mumbai-based cold chain cargo transporter, will deploy close 150 of its reefer trucks to transport these vaccines from the manufacturing plants of pharma companies to storage facilities across the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2021 Category: Pharmaceuticals Source Type: news

COVID-19 vaccine race: Main candidates and where they stand
Co-developed by the University of Oxford and British-Swedish company AstraZeneca and known as Covishield in India, the vaccine was the first on which a scientific study was published based on Phase 3 clinical trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2021 Category: Pharmaceuticals Source Type: news

Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in US
The drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 40 mg in the US market, the latest Enforcement Report by the USFDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2021 Category: Pharmaceuticals Source Type: news